ArticleAnnals of internal medicine2019
In poorly controlled type 2 diabetes, oral semaglutide was noninferior to liraglutide for reducing HbA1c.
Lorraine L LipscombePubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it